Search
Patexia Research
Case number 1:17-cv-00815

Amgen Inc. v. Alkem Laboratories Ltd. > Documents

Date Field Doc. No.Description (Pages)
Jun 20, 2020 1 Complaint (8)
May 9, 2018 58 SO ORDERED (2)
Docket Text: SO ORDERED - re [56] Stipulation of Admissibility (between Plaintiff and Alkem Laboratories Ltd.) filed by Amgen Inc. Signed by Judge Gregory M. Sleet on 5/9/2018. (mdb)
May 9, 2018 60 Patent/Trademark Report to Commissioner (5)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb)
May 9, 2018 59 SO ORDERED (4)
Docket Text: SO ORDERED - re [57] Proposed Consent Judgment filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 5/9/2018. ***Civil Case Terminated*** (mdb)
May 3, 2018 56 Stipulation (2)
Docket Text: STIPULATION of Admissibility (between Plaintiff and Alkem Laboratories Ltd.) by Amgen Inc.. (Blumenfeld, Jack)
May 3, 2018 57 Proposed Consent Judgment (4)
Docket Text: PROPOSED CONSENT JUDGMENT (between Plaintiff and Alkem Laboratories Ltd.) by Amgen Inc.. (Blumenfeld, Jack) Modified on 5/3/2018 (mdb).
Apr 23, 2018 54 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Responses to Alkem's First Requests for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
Apr 23, 2018 55 SO ORDERED (3)
Docket Text: SO ORDERED - re [53] Stipulation of Dismissal (between Plaintiff and Lupin Defendants) filed by Amgen Inc., Party Lupin Ltd. and Lupin Pharmaceuticals, Inc. terminated. Signed by Judge Gregory M. Sleet on 4/23/2018. (mdb)
Apr 19, 2018 53 Stipulation of Dismissal (3)
Docket Text: STIPULATION of Dismissal (between Plaintiff and Lupin Defendants) by Amgen Inc.. (Blumenfeld, Jack) Modified on 4/19/2018 (mdb).
Apr 17, 2018 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Joseph Schramm, III for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Apr 16, 2018 N/A Add Attorneys Pro Hac Vice (0)
Apr 16, 2018 N/A SO ORDERED (0)
Apr 13, 2018 52 Proposed Order (25)
Docket Text: PROPOSED ORDER -- Stipulated Protective Order -- by Amgen Inc.. (Blumenfeld, Jack)
Apr 13, 2018 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The Oral Order dated 4/13/2018 regarding a discovery telephone conference was entered on the docket in error and has been deleted. (ctd)
Apr 11, 2018 51 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin's Objections And Responses To Plaintiff's First Set Of Requests For The Production Of Documents And Things And Lupin's Objections And Responses To Plaintiff's First Set Of Interrogatories To Lupin (Nos. 1-7) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Murphy, Francis)
Apr 11, 2018 50 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph Schramm, III - filed by Alkem Laboratories Ltd.. (Schladweiler, Benjamin)
Apr 11, 2018 N/A SO ORDERED (0)
Apr 10, 2018 49 SO ORDERED (4)
Docket Text: SO ORDERED - re [43] Proposed Consent Judgment filed by Amgen Inc., CONSENT JUDGMENT, Party Macleods Pharma USA, Inc. and Macleods Pharmaceuticals, Ltd. terminated. Signed by Judge Gregory M. Sleet on 4/10/2018. (mdb)
Apr 10, 2018 48 SO ORDERED (2)
Docket Text: SO ORDERED - re (42 in 1:17-cv-00815-GMS, 50 in 1:17-cv-00817-GMS) Stipulation of Admissibility filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 4/10/2018. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(mdb)
Apr 10, 2018 47 Letter (1)
Docket Text: Letter to The Honorable Gregory M. Sleet from Jack B. Blumenfeld regarding Settlement Agreement between Amgen and Macleods - re Oral Order. (Blumenfeld, Jack)
Apr 10, 2018 N/A Oral Order (0)
Docket Text: ORAL ORDER re [47] Letter - The plaintiff shall send someone over to pick up the in-camera document today by 4:30 PM outside of Judge Sleet's Chambers. Ordered by Judge Gregory M. Sleet on 4/10/2018. (mdb)
Apr 9, 2018 46 Main Document (5)
Docket Text: REDACTED VERSION of [45] MOTION for Leave to File Amended Complaint by Amgen Inc.. (Attachments: # (1) Exhibit 1, A to Exhibit 1, 2, and 3)(Blumenfeld, Jack)
Apr 9, 2018 46 Exhibit 1, A to Exhibit 1, 2, and 3 (39)
Apr 9, 2018 46 Redacted Document (5)
Apr 6, 2018 N/A Oral Order (0)
Apr 2, 2018 44 Notice (Other) (2)
Docket Text: NOTICE of Withdrawal of Appearance of Scott B. Feder with Locke Lord by Lupin Ltd., Lupin Pharmaceuticals, Inc. (Murphy, Francis)
Mar 30, 2018 43 Proposed Consent Judgment (4)
Docket Text: PROPOSED CONSENT JUDGMENT by Amgen Inc.. (Blumenfeld, Jack)
Mar 30, 2018 42 Stipulation (2)
Docket Text: STIPULATION of Admissibility by Amgen Inc.. (Blumenfeld, Jack)
Mar 30, 2018 41 Notice (Other) (4)
Docket Text: NOTICE of Withdrawal of Counsel of Nicholas D. Mozal by Alkem Laboratories Ltd. (Mozal, Nicholas)
Mar 29, 2018 40 Transcript (26)
Docket Text: Official Transcript of Telephone Conference held on 03 26 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/19/2018. Redacted Transcript Deadline set for 4/30/2018. Release of Transcript Restriction set for 6/27/2018. (kjm)
Mar 26, 2018 39 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Nicholas D. Mozal on behalf of Alkem Laboratories Ltd. (Mozal, Nicholas)
Mar 26, 2018 38 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary Ji - filed by Alkem Laboratories Ltd.. (Schladweiler, Benjamin)
Mar 26, 2018 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Discovery Telephone Conference (#1) held on 3/26/2018. Arguments concerning the protective order issues outlined in the Joint Agenda Letter ([36]). The court treats the issues as motions and will deny them. (Court Reporter Kevin Maurer.) (mdb)
Mar 26, 2018 N/A SO ORDERED (0)
Mar 23, 2018 37 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' First Requests for the Production of Documents and Things (Nos. 1-62) filed by Alkem Laboratories Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Schladweiler, Benjamin)
Mar 20, 2018 N/A Oral Order (0)
Mar 16, 2018 36 Letter (2)
Docket Text: Letter to The Honorable Gregory M. Sleet from Francis J. Murphy, Esq. regarding Agenda for Discovery Teleconference on March 20, 2018 at 2:00 pm - re Oral Order,,. (Murphy, Francis)
Mar 5, 2018 35 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of (i) Defendant's Responses and Objections to Plaintiff's First Set of Requests for Documents (Nos. 1-62), and (ii) Defendant's Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-7) filed by Alkem Laboratories Ltd..(Schladweiler, Benjamin)
Feb 28, 2018 N/A Add Attorneys Pro Hac Vice (0)
Feb 21, 2018 N/A Oral Order (0)
Feb 15, 2018 N/A SO ORDERED (0)
Feb 14, 2018 34 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to File Protective Order to February 21, 2018 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis)
Feb 8, 2018 N/A SO ORDERED (0)
Feb 7, 2018 33 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to File Protective Order to February 14, 2018 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis)
Feb 5, 2018 N/A SO ORDERED (0)
Feb 2, 2018 32 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to File Protective Order to February 7, 2018 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis)
Feb 2, 2018 31 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Alkem; (2) Plaintiff's First Set of Requests to Alkem for the Production of Documents and Things; (3) Plaintiff's First Set of Interrogatories to Lupin; (4) Plaintiff's First Set of Requests to Lupin for the Production of Documents and Things; (5) Plaintiff's First Set of Interrogatories to Macleods; (6) Plaintiff's First Set of Requests to Macleods for the Production of Documents and Things; and (7) Plaintiff's Second Set of Requests to Macleods for the Production of Documents and Things filed by Amgen Inc..(Noreika, Maryellen)
Feb 1, 2018 30 Order (3)
Docket Text: ORDER On or before March 1, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in this Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/1/18. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(cak)
Jan 29, 2018 N/A SO ORDERED (0)
Jan 26, 2018 29 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to File Protective Order to February 2, 2018 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis)
Jan 25, 2018 N/A SO ORDERED (0)
Jan 22, 2018 28 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Protective Order to January 26, 2018 - filed by Amgen Inc.. (Noreika, Maryellen)
Jan 16, 2018 N/A SO ORDERED (0)
Jan 12, 2018 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
Jan 12, 2018 27 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a protective order to January 19, 2018 - filed by Amgen Inc.. (Noreika, Maryellen)
Jan 9, 2018 N/A SO ORDERED (0)
Jan 5, 2018 26 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a protective order to January 12, 2018 - filed by Amgen Inc.. (Noreika, Maryellen)
Dec 27, 2017 N/A SO ORDERED (0)
Dec 26, 2017 25 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Protective Order to January 5, 2018 - filed by Amgen Inc.. (Blumenfeld, Jack)
Dec 19, 2017 24 Order (2)
Docket Text: ORDER denying (18 in 1:17-cv-00817-GMS) MOTION for Judgment on the Pleadings filed by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc., denying (20 in 1:17-cv-00817-GMS) MOTION for Sanctions filed by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc., re (47 in 1:17-cv-00817-GMS, 23 in 1:17-cv-00815-GMS) Memorandum Opinion. Signed by Judge Gregory M. Sleet on 12/19/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(asw)
Dec 19, 2017 23 Memorandum Opinion (5)
Docket Text: MEMORANDUM OPINION re [18]Motion for Judgment on the Pleadings, re [20] Motion for Sanctions in C.A. No. 17-817 GMS. Signed by Judge Gregory M. Sleet on 12/19/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00817-GMS(asw)
Dec 15, 2017 22 Notice of Substitution of Counsel (1)
Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Alkem Laboratories Ltd.: Entry of appearance of attorney Benjamin J. Schladweiler. Attorney Kenneth L. Dorsney, Esquire, and the law firm of Morris James LLP terminated. (Schladweiler, Benjamin)
Dec 14, 2017 N/A SO ORDERED (0)
Dec 13, 2017 N/A CORRECTING ENTRY: (0)
Dec 13, 2017 N/A Remark (0)
Docket Text: Remark - These cases have been consolidated for ALL PURPOSES. All future filings will be made ONLY in Lead C.A. No. 17-815-GMS. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb)
Dec 11, 2017 21 Proposed Order (6)
Dec 11, 2017 21 Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order (1)
Dec 11, 2017 21 Main Document (6)
Docket Text: PROPOSED ORDER -- Scheduling Order -- by Amgen Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order)(Noreika, Maryellen) (Main Document 21 replaced on 12/13/2017) (mdb).
Nov 29, 2017 20 Transcript (24)
Docket Text: Official Transcript of Conference held on 11 20 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/20/2017. Redacted Transcript Deadline set for 1/2/2018. Release of Transcript Restriction set for 2/27/2018. (kjm)
Nov 20, 2017 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 11/20/2017. Discussion regarding the contents and differences in the joint status report. The Sherman Antitrust Act counterclaims are STAYED pending resolution of the patent claims. These cases will be consolidated for all purposes, including trial. A 5-day bench trial is set for 4/29/2019 at 9:00 AM in Courtroom 4A, and a Markman Hearing (1/2 day) is set for 4/2/2018 at 9:30 AM in Courtroom 4A, unless otherwise notified by the parties. The defendants will consult with their clients and inform the court, via the proposed amended scheduling order, if the Markman Hearing is necessary. The proposed amended scheduling order is due by 12/11/2017. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-00817-GMS, 1:17-cv-00815-GMS, 1:17-cv-00816-GMS(mdb)
Nov 9, 2017 N/A Oral Order (0)
Nov 3, 2017 19 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Alkem filed by Amgen Inc..(Noreika, Maryellen)
Oct 25, 2017 18 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Ltd.'s ANDA Production per the requirements of Paragraph 4(b) Disclosures filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Oct 20, 2017 N/A SO ORDERED (0)
Oct 18, 2017 16 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Rule 26(a)(1) Initial Disclosures to Alkem; (2) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 to Alkem; and (3) Plaintiff's Default Standard Paragraph 4(a) Disclosures to Alkem filed by Amgen Inc..(Noreika, Maryellen)
Oct 18, 2017 15 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s Rule 26(a)(1) Initial Disclosures and Paragraph 3 Disclosures filed by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Oct 18, 2017 17 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Manak - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Oct 12, 2017 N/A SO ORDERED (0)
Oct 11, 2017 14 Status Report (25)
Docket Text: Joint STATUS REPORT by Amgen Inc.. (Noreika, Maryellen)
Oct 11, 2017 13 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Oct 4, 2017 12 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to file Joint Status Report to October 11, 2017 - filed by Alkem Laboratories Ltd.. (Murphy, Francis)
Oct 4, 2017 N/A SO ORDERED (0)
Sep 21, 2017 N/A SO ORDERED (0)
Sep 20, 2017 11 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report to October 4, 2017 - filed by Amgen Inc.. (Noreika, Maryellen)
Aug 21, 2017 10 Order (2)
Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 8/21/2017. (asw)
Aug 18, 2017 9 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Aug 18, 2017 8 Answer to Complaint (6)
Docket Text: ANSWER to [1] Complaint , COUNTERCLAIM against Amgen Inc. by Alkem Laboratories Ltd..(Dorsney, Kenneth)
Jul 21, 2017 N/A SO ORDERED (0)
Jul 19, 2017 7 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendant Alkem Laboratories Ltd. to answer, move or otherwise respond to the Complaint to August 18, 2017 - filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
Jun 29, 2017 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Amgen Inc.. Alkem Laboratories Ltd. served on 6/28/2017, answer due 7/19/2017. (Blumenfeld, Jack)
Jun 28, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS (rjb)
Jun 23, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Ltd. on 6/26/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
Jun 23, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc. (nmg)
Jun 23, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2. (nmg)
Jun 23, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/31/2017. Date of Expiration of Patent: 9/22/2026. (nmg)
Jun 23, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jun 23, 2017 1 Main Document (8)
Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2170199.) - filed by Amgen Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg)
Jun 23, 2017 1 Civil Cover Sheet (1)
Jun 23, 2017 1 Exhibit A (14)
Jun 23, 2017 1 Complaint* (1)
Menu